CDKN2AIP antibody (C-Term)
Quick Overview for CDKN2AIP antibody (C-Term) (ABIN629922)
Target
See all CDKN2AIP AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- CARF antibody was raised against the C terminal Of Carf
-
Purification
- Purified
-
Immunogen
- CARF antibody was raised using the C terminal Of Carf corresponding to a region with amino acids AIEALKATLDVFFVPLKELADLPQNKSSQESIVCELRCKSVYLGTGCGKS
-
-
-
-
Application Notes
-
WB: 0.3125 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CARF Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CARF antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CARF antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CDKN2AIP (CDKN2A Interacting Protein (CDKN2AIP))
-
Alternative Name
- CARF
-
Background
- CARF was first cloned as a novel binding partner of ARF from a yeast-interactive screen. CARF and ARF colocalize in the perinucleolar region and have a collaborative function. In the nucleoplasm, CARF interacts with p53 and enhances its function. The p53 downregulates CARF in a negative feedback regulatory loop and may also involve p53 antagonist HDM2.
-
Molecular Weight
- 64 kDa (MW of target protein)
Target
-